Form EFFECT Lyra Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 |
| Accession Number: | 0001193125-26-124481 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ELEGOO Launches Open-Frame Centauri 2 Series: Bringing Fast, Accessible Multicolor 3D Printing to Everyone
- Government Contracts Built Billion-Dollar Businesses. Could ZenaTech (Nasdaq: ZENA) Be Next? (LDOS, BAH, CACI)
- Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
